STOCK TITAN
  1. Home
  2. Sec-filings
  3. HQY
  4. [Form 4] HEALTHEQUITY, INC. Insider Trading Activity

HealthEquity (HQY) founder discloses Form 4 sale of 791 shares in Jan 2026

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

HealthEquity director and officer Stephen Neeleman reported a disposition of 791 shares of common stock on January 9, 2026, at a weighted average price of $95.2367, leaving 110,744 shares held directly. The filing notes the shares were sold in multiple trades within a narrow price range.

He also reports indirect ownership of common stock held by the Stephen and Christine Neeleman Trust (409,735 shares), his spouse (140,000 shares, with beneficial ownership disclaimed), and Neeleman Family Holdings, LLC (203,000 shares, with beneficial ownership disclaimed except for pecuniary interest. In addition, he holds stock options immediately exercisable for 19,897 shares at $41.28, 14,228 shares at $61.72, and 15,337 shares at $73.61.

Positive

  • None.

Negative

  • None.
Insider Neeleman Stephen
Role FOUNDER AND VICE CHAIRMAN
Type Security Shares Price Value
Tax Withholding Common Stock 791 $95.2367 $75K
holding Stock Option (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 110,744 shares (Direct); Stock Option (right to buy) — 19,897 shares (Direct); Stock Options (right to buy) — 14,228 shares (Direct); Common Stock — 409,735 shares (Indirect, See footnote)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.2357 to $95.2376 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 of this Form 4. Shares held of record by the Stephen and Christine Neeleman Trust. The securities are beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes. The option is immediately exercisable.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neeleman Stephen
(Last) (First) (Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
(Street)
DRAPER UT 84020
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
FOUNDER AND VICE CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/09/2026 F 791 D $95.2367(1) 110,744 D
Common Stock 409,735 I See footnote(2)
Common Stock 140,000 I See footnote(3)
Common Stock 203,000 I See footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $41.28 (5) 03/27/2027 Common Stock 19,897 19,897 D
Stock Options (right to buy) $61.72 (5) 03/27/2028 Common Stock 14,228 14,228 D
Stock Options (right to buy) $73.61 (5) 03/26/2029 Common Stock 15,337 15,337 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.2357 to $95.2376 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 of this Form 4.
2. Shares held of record by the Stephen and Christine Neeleman Trust.
3. The securities are beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
4. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
5. The option is immediately exercisable.
/s/ Stephen Neeleman 01/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Stephen Neeleman report for HQY?

Stephen Neeleman reported a disposition of 791 shares of HealthEquity common stock on January 9, 2026, at a weighted average price of $95.2367 per share.

How many HealthEquity (HQY) shares does Stephen Neeleman hold directly after this Form 4?

After the reported transaction, Stephen Neeleman directly holds 110,744 shares of HealthEquity common stock.

What indirect HealthEquity share holdings are associated with Stephen Neeleman?

Indirect holdings include 409,735 shares held by the Stephen and Christine Neeleman Trust, 140,000 shares beneficially owned by his spouse, and 203,000 shares held by Neeleman Family Holdings, LLC.

Does Stephen Neeleman disclaim beneficial ownership of any HQY shares?

Yes. He disclaims beneficial ownership of shares beneficially owned by his spouse and, except for his pecuniary interest, of shares held by Neeleman Family Holdings, LLC.

What stock options did Stephen Neeleman report in this Form 4 for HQY?

He reports stock options immediately exercisable for 19,897 shares at $41.28, 14,228 shares at $61.72, and 15,337 shares at $73.61 of HealthEquity common stock.

What does the weighted average price disclosure mean in this HQY Form 4?

The filing states the $95.2367 price is a weighted average for multiple trades between $95.2357 and $95.2376, and detailed trade data is available on request.